November 3, 2021
Wacky, Crazy or both
We haven’t quite decided whether our wacky world has transformed from just being wacky to being outright crazy. Yet looking at some recent announcements we are beginning to believe that if we have not reached full blown crazy already, we are well on our way to full blown crazy. However, before we get to crazy let’s make a few observations on the results Novo Nordisk released this morning.
1. Not sure how many ways we can say this, but Novo is now a full blown GLP-1 company with Obesity NOT diabetes being the driving force.
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.